Crane HM - Search Results

1

An internationally generalizable risk index for mortality after one year of antiretroviral therapy.

Tate JP, Justice AC, Hughes MD, Bonnet F, Reiss P, Mocroft A, Nattermann J, Lampe FC, Bucher HC, Sterling TR, Crane HM, Kitahata MM, May M, Sterne JA. Tate JP, et al. Among authors: crane hm. AIDS. 2013 Feb 20;27(4):563-72. doi: 10.1097/QAD.0b013e32835b8c7f. AIDS. 2013. PMID: 23095314 Free PMC article.

2

Diabetes case identification methods applied to electronic medical record systems: their use in HIV-infected patients.

Crane HM, Kadane JB, Crane PK, Kitahata MM. Crane HM, et al. Among authors: crane pk. Curr HIV Res. 2006 Jan;4(1):97-106. doi: 10.2174/157016206775197637. Curr HIV Res. 2006. PMID: 16454715

3

A single-item measure of health-related quality-of-life for HIV-infected patients in routine clinical care.

Crane HM, Van Rompaey SE, Dillingham PW, Herman E, Diehr P, Kitahata MM. Crane HM, et al. AIDS Patient Care STDS. 2006 Mar;20(3):161-74. doi: 10.1089/apc.2006.20.161. AIDS Patient Care STDS. 2006. PMID: 16548713

4

Antiretroviral medications associated with elevated blood pressure among patients receiving highly active antiretroviral therapy.

Crane HM, Van Rompaey SE, Kitahata MM. Crane HM, et al. AIDS. 2006 Apr 24;20(7):1019-26. doi: 10.1097/01.aids.0000222074.45372.00. AIDS. 2006. PMID: 16603854

5

Routine collection of patient-reported outcomes in an HIV clinic setting: the first 100 patients.

Crane HM, Lober W, Webster E, Harrington RD, Crane PK, Davis TE, Kitahata MM. Crane HM, et al. Among authors: crane pk. Curr HIV Res. 2007 Jan;5(1):109-18. doi: 10.2174/157016207779316369. Curr HIV Res. 2007. PMID: 17266562

6

Amprenavir and didanosine are associated with declining kidney function among patients receiving tenofovir.

Crane HM, Kestenbaum B, Harrington RD, Kitahata MM. Crane HM, et al. AIDS. 2007 Jul 11;21(11):1431-9. doi: 10.1097/QAD.0b013e3281fc9320. AIDS. 2007. PMID: 17589189

7

Blood pressure and antiretroviral therapy.

Crane HM, Van Rompaey SE, Kitahata MM. Crane HM, et al. AIDS. 2007 Sep 12;21(14):1992-3. doi: 10.1097/QAD.0b013e3282ef7942. AIDS. 2007. PMID: 17721117 No abstract available.

8

Initiating highly active antiretroviral therapy with newer protease inhibitors is associated with better survival compared to first-generation protease inhibitors or nevirapine.

Crane HM, Van Rompaey SE, Kitahata MM. Crane HM, et al. AIDS Patient Care STDS. 2007 Dec;21(12):920-9. doi: 10.1089/apc.2007.0020. AIDS Patient Care STDS. 2007. PMID: 18154489

9

The effect of mental illness, substance use, and treatment for depression on the initiation of highly active antiretroviral therapy among HIV-infected individuals.

Tegger MK, Crane HM, Tapia KA, Uldall KK, Holte SE, Kitahata MM. Tegger MK, et al. Among authors: crane hm. AIDS Patient Care STDS. 2008 Mar;22(3):233-43. doi: 10.1089/apc.2007.0092. AIDS Patient Care STDS. 2008. PMID: 18290749

10

Tenofovir-associated decline in renal function.

Crane HM, Kestenbaum B, Harrington RD, Kitahata MM. Crane HM, et al. J Infect Dis. 2008 Sep 15;198(6):937; author reply 937-8. doi: 10.1086/591135. J Infect Dis. 2008. PMID: 18721062 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

324 results

Search Page

Filters